(MENAFNEditorial)
(OTCBB: UBIQ) Ubiquity Inc. is based in Irvine CA. Ubiquity is a vertically integrated technology-focused media company that focuses in five specific areas with a robust portfolio of patents and intellectual property.
Ubiquity Inc. recently announced that it has signed signed an agreement to acquire Coversant Inc. Coversant is a developer of a SoapBox platform classified as an "Internet of Things Service Bus" (IoT-SB) which can securely and efficiently connect devices sensors and actuators to users applications and databases for data analysis and process control. The SoapBox IoT-SB is one of two software platforms in the world that has passed rigorous Defense Information Systems Agency and placed on the Unified Capabilities Approved Product List (UCAPL). The SoapBox protocol based on XMPP is mandated by the Department of Defense for real time communication for voice video chat messaging and presence. In the full year ended 2014 Coversant recorded revenues of approximately $1.2 million.
(OTCQB: ISCO) International Stem Cell Corporation a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology parthenogenesis results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos.
International Stem Cell Corporation recently announced that it has completed manufacturing of the cell bank of clinical-grade human neural stem cells using its patented process for the recently announced phase 1/2a clinical trial in Parkinson's disease. The cell bank contains over 2.6 billion human cells sufficient to meet the company's foreseeable clinical trial requirements.
According to the National Institutes of Health in 2013 over $146 million was spent on human stem cells embryonic research and over $431 million was spent on non-embryonic research.
(OTC Pinks: SUTI) Sutimco Interinational Inc. is a development corporation with focus and design to enter a new and emerging medical and recreational use marijuana market sectors.
It recently announces that is has introduced a new direction business plan and future market development for the company.
Researches from The ArcView Group a cannabis industry investment and research firm based in Oakland California found that the U.S. market for the U.S. market for legal cannabis grew 74 percent in 2014 to $2.7 billion up from $1.5 billion in 2013.
The group surveyed hundreds of medical and recreational marijuana retailers in states where sales are legal as well as ancillary business operators and independent cultivators of the plant over the course of seven months during 2013 and 2014. ArcView also compiled data from state agencies nonprofit organizations and private companies in the marijuana industry for a more complete look at the marketplace.
(OTC Pinks: TDEY).3D Entertainment Holdings Inc. a Wyoming Corporation dba 3D Eye Solutions Inc. recently announced that it has signed an acquisition MOU with Oak River Technologies LLC. (dba) Employer Now Development Company (ENDCO). ENDCO is a technology and software development/ design company designed to process and enhance the processing and experience for insurance companies and their potential clients.
Health spending continues to grow and according to the Center for Medicare & Medicaid Services in 2013 health spending growth expenditures in the United States reached $2.9 trillion or $9255 per person.
According to Technology Business Research Inc the healthcare industry spent over $34.5 billion on technology and software in 2013. Providers payers and physician groups will be spending over $69 billion on healthcare related IT services over the next six years according to a market research study released by the Mountain Lakes N.J.-based Insight Research Corporation.
About PubcosPix
This newsletter is a NOT a paid advertisement NOT a recommendation NOR an offer to buy or sell securities. This report is owned operated and edited by PubcosPix reporter. Our business model is strickly for information and news reporting and is held to the standards of ‘Freedom of the Press’. PubcosPix is NOT financially compensated to market or promote public companies. By reading our writings and our website you agree to the terms of our disclaimer which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk so only invest what you can afford to lose. By using our service you agree not to hold our site its editor’s owners or staff liable for any damages financial or otherwise that may occur due to any action you may take based on the information contained within our reports or on our website. We do not advise any reader take any specific action.
If you wish to have a company covered in more detail by our team or wish to learn more about our services please contact us at pubcopix@gmail.com.
Contact:
Orlando Medina
pubcopix@gmail.com
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.